Feel for the holders here. Bio's are easily the highest risk stock to punt on. Been burnt many times in the past and have realised that you make more money with the bounce from heavy selling after it fails as opposed to holding on for positive results unless you entered very low.
Have hardly seen any small bio's become the next pharma giant, its a real punt on results. Long wait times and lots of capital raise. Its either you lose 80% of your money or you get 800%, hardly any inbetween.
On that note, the company still has a decent amount of cash from the looks of things. Probably lots of tax loss selling happening right now.
Ann: Topline Six-Month Results From Phase IIb Study of Avicursen, page-98
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
-0.001(10.0%) |
Mkt cap ! $9.786M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.0¢ | 0.9¢ | $94.66K | 10.09M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 661860 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 1588275 | 6 |
View Market Depth
| Last trade - 15.52pm 27/06/2025 (20 minute delay) ? |
| PER (ASX) Chart |